AstraZeneca
Also known as: 1326 Riverview Road Ext Lexington, NC 27292-1764 USA | ALEXION PHARMS INC | AstraZeneca | ASTRAZENECA | AstraZeneca1800 Concord PikeWilmington, DE, 19850 | AstraZeneca 180 Concord Pike Wilmington, DE 19850-5437 | AstraZeneca 180 Concord Pike, Wilmington,DE 19850-5437 | AstraZeneca,1F64, Mereside, Alderley Park, Macclesfield, Cheshire,SK10 4TG UK | AstraZeneca AB | ASTRAZENECA AB | AstraZeneca Aderley Park | AstraZeneca AG, Grafenau 10; 6300 Zug; Switzerland | AstraZeneca Alderley Park | AstraZeneca, Alderley Park | AstraZeneca, Alderley Park, Cheshire, UK | Astrazeneca Alderley Park Macclesfield SK10 4TG United Kingdom | AstraZeneca, Alderley Park, UK | AstraZeneca Alderly Park1G61 Mereside, Alderly Park, Macclesfeld, Cheshire, England SK104TG | AstraZeneca Alderly Park CPU | Astrazeneca Alderly UK | AstraZeneca AS | AstraZeneca Barcelona | AstraZeneca, Biopharmaceuticals Medical | Astra Zeneca, Bristol-Myers Squibb | AstraZeneca, Bristol-Myers Squibb | AstraZeneca BV | AstraZeneca, Cambridge Science Park, US | AstraZeneca, Cambridge, UK | AstraZeneca Charnwood England | Astrazeneca China | AstraZeneca China MC | AstraZeneca, Clinical Pharamcology Unit, Alderley Park | AstraZeneca, Clinical Pharmacology Unit, Alderley Park | AstraZeneca Clinical Pharmacology Unit, AstraZeneca R&D Lund,Sweden | AstraZeneca, Clinical Pharmacology Unit at Sahlgrenska University Hospital, Sweden | AstraZeneca Clinical Pharmacology Unit, C2-84, Karolinska University Hospital Huddinge, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit (CPU) C2:84Karolinska University Hospital HuddingeSE-141 86 StockholmSweden | AstraZeneca Clinical Pharmacology Unit, E Floor, Queens Medical Centre, Nottingham NG7 2UH | AstraZeneca Clinical Pharmacology Unit, Lund | AstraZeneca Clinical Pharmacology Unit, Nottingham | AstraZeneca Clinical Pharmacology Unit, Queens Medical Centre, Nottingham NG7 2UH | AstraZeneca, Clinical Pharmacology Unit, Sahlgrenska University Hospital | AstraZeneca Clinical Pharmacology Unit, Stockholm | Astrazeneca Clinical Pharmacology Unit, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit, Stockholm, Sweden | AstraZeneca Clinical Pharmacology Unit, US | AstraZeneca CPU Alderley Park, United Kingdom | AstraZeneca CPU Huddinge | AstraZeneca CPU, Philadelphia | AstraZeneca CPU, Philadelphia, PA | AstraZeneca, Denmark | Astrazeneca (direct) | AstraZeneca employee | AstraZeneca Finland | AstraZeneca Germany | AstraZeneca Global Medicines Development, Academy House | AstraZeneca Global R&D, Alderley park, Cheshire, SK10 4TG, UK | AstraZeneca, Hertfordshire, UK | AstraZeneca Investment (China) Co., Ltd | AstraZeneca Japan | Astra Zeneca K.K. | AstraZeneca KK | AstraZeneca K.K. | AstraZeneca KK Corporate Communications | AstraZeneca KK - Pharmaceuticals | AstraZeneca Korea | AstraZeneca Kvambergagatan 12, 15185, Sodertalje, Sweden | AstraZeneca Kvzmbergagatan 12, 15185,Sodertalje, Sweden | ASTRAZENECA LP | AstraZeneca, LP, 1800 Concord Pike, Wilmington, DE | AstraZeneca, MC France | AstraZeneca MC Sweden | AstraZeneca Medical Science Director | AstraZeneca, Medical Science Director | AstraZeneca Mexico | AstraZeneca, Moelndal, Sweden | Astrazeneca Molndal, Sweden | Astrazeneca, Molndal, Sweden | AstraZeneca Molndal Sweden | AstraZeneca Molndal, Sweden | AstraZenecaMolndal Sweden | AstraZeneca NV/SA | AstraZeneca, Osaka, Japan | AstraZeneca, Parklands, Alderley Park | AstraZeneca,Parklands, Alderley Park | AstraZeneca, Pepparedsleden 1 431 83 Molndal Sweden | AstraZeneca Pharmaceutical | AstraZeneca Pharmaceutical Co., Ltd., Shanghai, China | AstraZeneca Pharmaceuticals 35 Gathouse Drive, Waltham, Ma 02451 United States | AstraZeneca Pharmaceuticals;C2C-716 1800 Concord PikePO. Box 15437Wilmington De 19850-5437 | AstraZeneca PharmaceuticalsC2C-7161800 Concord PikePO. Box 15437Wilmington De 19850-5437 | AstraZeneca PharmaceuticalsKvarnbergagatan 12, 15185, Sodertalje, Sweden | AstraZeneca Pharmaceuticals, Kvarnbergagatan 12S-151 85, Sodertalje, Sweden | AstraZeneca Pharmaceuticals PLC | AstraZeneca Pharmaceuticals Room C3B-718PO Box 15437 Wilmington, DE 19850-5437 USA | AstraZeneca PharmaceuticalsRoom C3B-718PO Box 15437Wilmington, DE 19850-5437 USA | AstraZeneca Pharmaceuticals-US | AstraZeneca Pharmaceuticals, Wilm DE | AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437 USA | AstraZeneca Pharmaceuticals, Wilmington, UK | ASTRAZENECA PHARMS | AstraZeneca R&D | AstraZeneca R&D, 35 Gatehouse Drive, MA 02451 USA | AstraZeneca R&D, Alderley Park, UK | AstraZeneca R&D Alderly Park, Mereside SK 104 TG Macclesfield, Cheshire United Kingdom | AstraZeneca R&D, Alderly Park, Mereside, SK 104TG, Macclesfield, Cheshire, United Kingdom | AstraZeneca R&D Alderly Park, Parklands, SK 104TF, Macclesfield, Cheshire, United Kingdom | AstraZeneca R&D BioPharmaceuticals | AstraZeneca R&D Boston | AstraZeneca R&D Boston, United States | AstraZeneca R&D Charnwood | AstraZeneca R&D, Charnwood, UK | AstraZeneca R&D, CPU Alderley Park, UK | AstraZeneca R&D CPU Karolinska University Hospital, Stockholm | AstraZeneca R&D CPU Nottingham, UK | AstraZeneca R&D, Gothenburg, Sweden | AstraZeneca R&D Japan | AstraZeneca R&D Lund | AstraZeneca R&D, Lund | AstraZeneca R&D Lund, Sweden | AstraZeneca R&D, Lund, Sweden | AstraZeneca, R&D, Lund, Sweden | AstraZeneca R&D Mölndal | AstraZeneca R&D Molndal | AstraZeneca R&D Molndal, Sweden | AstraZeneca R&D, Molndal Sweden | AstraZeneca R&DMolndal, Sweden | AstraZeneca R&D Sodertalje, SE-151 85 Sodertalje, Sweden | AstraZeneca R&D, Sodertalje, Sweden | AstraZeneca R&D, Wilmington | AstraZeneca R&D Wilmington, USA | AstraZeneca Research and Development SE-431 83 Molndal Sweden | AstraZeneca Research and DevelopmentSE-431 83 MolndalSweden | AstraZeneca Research & Development | AstraZeneca Research & Development, Neuroscience iMed, 141 Portland Street, Cambridge, MA 02139 | AstraZeneca Senior Research Physician | AstraZeneca Singapore Pte Ltd | Astrazeneca Sodertalje Sweden | Astrazeneca, Sodertalje Sweden | Astra Zeneca, Sodertalje, Sweden | AstraZeneca, Sodertalje Sweden | AstraZeneca Spain | AstraZeneca SpA, Medical Dept., Basiglio, ITALY | AstraZeneca Sponsor Research Physician | AstraZeneca Study Statistician | Astrazeneca Sweden | AstraZeneca Sweden | AstraZeneca Sweden AB | Astrazeneca UK | Astrazeneca, UK | AstraZeneca UK | AstraZeneca UK Limited | AstraZeneca UK Ltd | ASTRAZENECA UK LTD | AstraZeneca UK, MSD | Astrazeneca United kingdom | Astrazeneca, Waltham, MA, United States | AstraZeneca Wilmington | AstraZeneca Wilmington, DE United States | Astrazeneca Wilmington, US | Astrazeneca, Wilmington US | Astrazeneca, Wilmington, US | AstraZeneca Wilmington US | AstraZeneca, Wilmington US | AstraZeneca, Wilmington, US | AstraZeneca, Wilmington, USA | AstraZenenca | AZ | AZ Clinical Pharmacology Unit, Philadelphia, USA | AZD1386AstraZeneca R&D Wilmington, USA | AZ/Daiichi | AZ K.K | AZ K.K. | AZ Mondal R&D, Sweden | AZ Neuro | AZ Pharmaceuticals - China | AZ Pharmaceuticals - US | AZ Pharmaceuticals, US | AZ R&D Gaithersburg | AZ R&D, Gaithersburg | AztraZeneca, Tokyo, Japan | Bioventure Hub | Clinical Pharmacology UnitAlderley ParkAstraZenecaMacclesfieldSK10 4TG | Clinical Pharmacology Unit, AstraZeneca R&D Lund, Sweden | Cori Analyticals | Global Medicines Development | Medical Director AstraZeneca | Medical Director AstraZeneca goswamit@medimmune.com | Medical & Regulatory Affairs Director, AstraZeneca Greece: 4 | Medical Scientist AstraZeneca Anthony.Jarkowski@astrazeneca.com | Medicine and Sciences AstraZeneca | MedImmune, LLC | Molndal, Sweden AstraZeneca | Nexium Global Product Director, AstraZeneca | Physician Group, Clinical Division, R&D, Astrazeneca K.K. | Study Delievery Director, AstraZeneca | TOPROL | Wilmington, US AstraZeneca
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1999First marketed drug
Jan 1, 1999First NDA
Feb 13, 2001Last known activity
Oct 1, 2026
Timeline
1960s
- Apr 7, 1961
amitriptyline— NDA Secondary Org
1990s
- Jan 1, 1999
AstraZeneca— Founded
- Jan 1, 1999
Astra— Acquired
- Jan 1, 1999
Zeneca Pharmaceuticals— Acquired
2000s
- Dec 23, 2005
KuDOS— Acquired
- Jan 1, 2006
Cambridge Antibody Technology— Acquired
- Jan 1, 2007
Arrow Therapeutics— Acquired
- Jun 19, 2007
MedImmune— Acquired
- Dec 23, 2009
Novexel Inc— Acquired
2010s
- Jan 1, 2012
Ardea Biosciences— Acquired
- Jan 1, 2013
AlphaCore Pharma LLC— Acquired
- Jan 1, 2013
Amplimmune— Acquired
- Jan 1, 2013
Pearl Therapeutics— Acquired
- Jan 1, 2013
Spirogen— Acquired
- May 1, 2013
Omthera Pharmaceuticals— Acquired
- Jan 1, 2014
Allozyne— Acquired
- Jan 1, 2015
Acerta Pharma— Acquired
- Jan 1, 2015
Inovio Pharmaceuticals— Acquired
- Nov 6, 2015
ZS Pharma, Inc.— Acquired
2020s
- Apr 10, 2020
selumetinib— Marketing Organization
- Apr 10, 2020
selumetinib— NDA Organization
- Oct 13, 2020
Alexion— Acquired
- Jul 6, 2022
TeneoTwo— Acquired
- Oct 3, 2022
LogicBio Therapeutics— Acquired
- Jan 9, 2023
CinCor Pharma, Inc.— Acquired
- Dec 12, 2023
Icosavax, Inc.— Acquired
- Dec 26, 2023
Gracell Biotechnology Ltd.— Acquired
- Mar 14, 2024
Amolyt Pharma— Acquired
Drugs by trial phase (969 distinct, 4229 trials)
Phase 4 (84 own, 63 via acquisition)
Phase 3 (117 own, 81 via acquisition)
Phase 2 (204 own, 126 via acquisition)
Phase 1 (171 own, 111 via acquisition)
Other trials (11 own, 1 via acquisition)
Indications
Approved for
- Acute Coronary Syndrome
- Arthritis, Rheumatoid
- Asthma
- Atherosclerosis
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Cluster Headache
- Colitis, Microscopic
- Colitis, Ulcerative
- Constipation
- Crohn Disease
- Diabetes Mellitus, Type 2
- Duodenal Ulcer
- Dyslipidemias
- Esophagitis
- Gastroesophageal Reflux
- Hyperlipoproteinemia Type II
- Hyperlipoproteinemia Type III
- Hypertriglyceridemia
- Hyperuricemia
- Migraine Disorders
- Migraine with Aura
- Migraine without Aura
- Myocardial Infarction
- Osteoarthritis
- Ovarian Neoplasms
- Pulmonary Disease, Chronic Obstructive
- Rhinitis, Allergic, Perennial
- Spondylitis, Ankylosing
- Stomach Ulcer
- Thyroid Neoplasms
- Urinary Bladder Neoplasms
- Zollinger-Ellison Syndrome
Studied for
- Abdominal Pain
- Abscess
- ACTH-Secreting Pituitary Adenoma
- Acute Coronary Syndrome
- Acute Disease
- Adenocarcinoma
- Adenocarcinoma, Clear Cell
- Adenocarcinoma of Lung
- Adenomyoepithelioma
- Adrenocortical Carcinoma
- Affective Disorders, Psychotic
- Aggression
- Airway Obstruction
- Albuminuria
- Alcoholism
- Alzheimer Disease
- Amnesia
- Anemia
- Anemia, Sickle Cell
- Aneurysm
- Angina Pectoris
- Angina, Stable
- Anus Neoplasms
- Anxiety Disorders
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Aortic Valve Stenosis
- Arrhythmias, Cardiac
- Arteriosclerosis
- Arteriovenous Fistula
- Arthralgia
- Arthritis
- Arthritis, Juvenile
- Arthritis, Rheumatoid
- Asthma
- Asthma, Exercise-Induced
- Atherosclerosis
- Atrial Fibrillation
- Atrial Flutter
- Atrophy
- Attention Deficit Disorder with Hyperactivity
- Back Pain
- Bacterial Infections
- Barrett Esophagus
- Biliary Tract Neoplasms
- Bipolar Disorder
- Body Weight
- Bone Diseases
- Bone Neoplasms
- Borderline Personality Disorder
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Neoplasms
- Bronchial Diseases
- Bronchiectasis
- Bronchiolitis
- Bronchiolitis Obliterans
- Bronchitis
- Bronchitis, Chronic
- Bulbo-Spinal Atrophy, X-Linked
- Cancer Pain
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Ductal, Breast
- Carcinoma, Endometrioid
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Pancreatic Ductal
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinosarcoma
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiomyopathy, Hypertrophic
- Cardiotoxicity
- Cardiovascular Diseases
- Carotid Artery Diseases
- Carotid Body Tumor
- Carotid Stenosis
- Cellulitis
- Cerebral Hemorrhage
- Chest Pain
- Chickenpox
- Cholangiocarcinoma
- Chronic Disease
- Chronic Pain
- Churg-Strauss Syndrome
- Cluster Headache
- Cocaine-Related Disorders
- Cognitive Dysfunction
- Colitis
- Colitis, Collagenous
- Colitis, Lymphocytic
- Colitis, Ulcerative
Marketed drugs (68)
Subsidiaries (24 direct, 45 total across the full acquisition tree)
- Acerta Pharma
- Alexion
- Allozyne
- AlphaCore Pharma LLC
- Amolyt Pharma
- Amplimmune
- Ardea Biosciences
- Arrow Therapeutics
- Astra
- Cambridge Antibody Technology
- CinCor Pharma, Inc.
- Gracell Biotechnology Ltd.
- Icosavax, Inc.
- Inovio Pharmaceuticals
- KuDOS
- LogicBio Therapeutics
- MedImmune
- Novexel Inc
- Omthera Pharmaceuticals
- Pearl Therapeutics
- Spirogen
- TeneoTwo
- Zeneca Pharmaceuticals
- ZS Pharma, Inc.
- Achillion Pharmaceuticals L2
- Aptein L2
- Aviron L2
- Bioject Medical Technologies, Inc. L2
- Cellective Therapeutics L2
- Enobia Pharmaceuticals L2
- Hassle L2
- IntraBiotics Pharmaceuticals L2
- NeoRx L2
- Orphatech Pharmaceuticals, GmbH L2
- Poniard Pharmaceuticals L2
- Portola Pharmaceuticals L2
- Proliferon Inc. L2
- Synageva Biopharma L2
- Syntimmune, Inc. L2
- Taligen Therapeutics L2
- Tika L2
- US Bioscience L2
- VGX Pharmaceuticals, LLC L2
- Wilson Therapeutics AB L2
- Trimeris L3
Recent trials (50)
- NCT03501615Lead sponsorN/A—
- NCT04750057Lead sponsorN/A—
- NCT06279728CollaboratorN/A—
- NCT05345678Lead sponsorN/A—
- NCT03259633Lead sponsorN/A—
- NCT07175415CollaboratorPhase 1/Phase 2Oct 1, 2026
- NCT07295821Lead sponsorPhase 2Mar 9, 2026
- NCT07241065Lead sponsorPhase 1Jan 28, 2026
- NCT07279935Lead sponsorPhase 4Jan 15, 2026
- NCT07155226Lead sponsorPhase 1/Phase 2Jan 12, 2026
- NCT07312851Lead sponsorPhase 1Jan 12, 2026
- NCT07281833CollaboratorPhase 3Dec 31, 2025
- NCT07221253Lead sponsorPhase 3Dec 31, 2025
- NCT07224373Lead sponsorPhase 1Dec 23, 2025
- NCT07295847Lead sponsorPhase 1Dec 16, 2025
Details
- Founded
- London, GB Jan 1, 1999
- First NDA
- Feb 13, 2001
- Last known activity
- Oct 1, 2026
Designations held
- Orphan drug
- Fast track
- Priority review
- Breakthrough therapy
- Accelerated approval